APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microneedle Flu Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Microneedle Flu Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025189 pages

Choose your research edition.

Industry ResearchMicroneedle Flu Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Microneedle Flu Vaccine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Microneedle Flu Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microneedle Flu Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Microneedle Flu Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Microneedle Flu Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Microneedle Flu Vaccine include Sanofi, NanoPass Technologies, Microdermics and OraSure Technologies, GC Pharma, FluGen, Debiotech, CosMED Pharmaceuticals, Corium International and Becton Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Microneedle Flu Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microneedle Flu Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microneedle Flu Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Microneedle Flu Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Microneedle Flu Vaccine Segment by Company

Sanofi

NanoPass Technologies

Microdermics and OraSure Technologies

GC Pharma

FluGen

Debiotech

CosMED Pharmaceuticals

Corium International

Becton Dickinson and Company

Microneedle Flu Vaccine Segment by Type

Hollow Microneedle

Coated Microneedle

Solid Microneedle

Dissolving Microneedle

Microneedle Flu Vaccine Segment by Application

Influenza A

Influenza B

Microneedle Flu Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microneedle Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle Flu Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Microneedle Flu Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Microneedle Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Microneedle Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Microneedle Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Microneedle Flu Vaccine Industry Trends Table 2. Microneedle Flu Vaccine Industry Drivers Table 3. Microneedle Flu Vaccine Industry Opportunities and Challenges Table 4. Microneedle Flu Vaccine Industry Restraints Table 5. Global Microneedle Flu Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Microneedle Flu Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Microneedle Flu Vaccine Sales Market Share by Manufacturers Table 9. Global Microneedle Flu Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Microneedle Flu Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Microneedle Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Microneedle Flu Vaccine Manufacturers, Product Type & Application Table 13. Global Microneedle Flu Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Microneedle Flu Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hollow Microneedle Table 17. Major Manufacturers of Coated Microneedle Table 18. Major Manufacturers of Solid Microneedle Table 19. Major Manufacturers of Dissolving Microneedle Table 20. Global Microneedle Flu Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Global Microneedle Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 23. Global Microneedle Flu Vaccine Sales Market Share by Type (2021-2026) Table 24. Global Microneedle Flu Vaccine Sales Market Share by Type (2027-2032) Table 25. Global Microneedle Flu Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Microneedle Flu Vaccine Revenue by Type (2021-2026) & (K Units) Table 27. Global Microneedle Flu Vaccine Revenue by Type (2027-2032) & (K Units) Table 28. Global Microneedle Flu Vaccine Revenue Market Share by Type (2021-2026) Table 29. Global Microneedle Flu Vaccine Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Influenza A Table 31. Major Manufacturers of Influenza B Table 32. Global Microneedle Flu Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 34. Global Microneedle Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 35. Global Microneedle Flu Vaccine Sales Market Share by Application (2021-2026) Table 36. Global Microneedle Flu Vaccine Sales Market Share by Application (2027-2032) Table 37. Global Microneedle Flu Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Microneedle Flu Vaccine Revenue by Application (2021-2026) & (K Units) Table 39. Global Microneedle Flu Vaccine Revenue by Application (2027-2032) & (K Units) Table 40. Global Microneedle Flu Vaccine Revenue Market Share by Application (2021-2026) Table 41. Global Microneedle Flu Vaccine Revenue Market Share by Application (2027-2032) Table 42. Global Microneedle Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Microneedle Flu Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Microneedle Flu Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Microneedle Flu Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Microneedle Flu Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Microneedle Flu Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 49. North America Microneedle Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 50. Europe Microneedle Flu Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 52. Europe Microneedle Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Microneedle Flu Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Microneedle Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Microneedle Flu Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Microneedle Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Microneedle Flu Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Microneedle Flu Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Microneedle Flu Vaccine Revenue Market Share by Region (2021-2026) Table 63. Global Microneedle Flu Vaccine Revenue Market Share by Region (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sanofi Microneedle Flu Vaccine Product Portfolio Table 68. Sanofi Recent Development Table 69. NanoPass Technologies Company Information Table 70. NanoPass Technologies Business Overview Table 71. NanoPass Technologies Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. NanoPass Technologies Microneedle Flu Vaccine Product Portfolio Table 73. NanoPass Technologies Recent Development Table 74. Microdermics and OraSure Technologies Company Information Table 75. Microdermics and OraSure Technologies Business Overview Table 76. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio Table 78. Microdermics and OraSure Technologies Recent Development Table 79. GC Pharma Company Information Table 80. GC Pharma Business Overview Table 81. GC Pharma Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. GC Pharma Microneedle Flu Vaccine Product Portfolio Table 83. GC Pharma Recent Development Table 84. FluGen Company Information Table 85. FluGen Business Overview Table 86. FluGen Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. FluGen Microneedle Flu Vaccine Product Portfolio Table 88. FluGen Recent Development Table 89. Debiotech Company Information Table 90. Debiotech Business Overview Table 91. Debiotech Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Debiotech Microneedle Flu Vaccine Product Portfolio Table 93. Debiotech Recent Development Table 94. CosMED Pharmaceuticals Company Information Table 95. CosMED Pharmaceuticals Business Overview Table 96. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio Table 98. CosMED Pharmaceuticals Recent Development Table 99. Corium International Company Information Table 100. Corium International Business Overview Table 101. Corium International Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Corium International Microneedle Flu Vaccine Product Portfolio Table 103. Corium International Recent Development Table 104. Becton Dickinson and Company Company Information Table 105. Becton Dickinson and Company Business Overview Table 106. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio Table 108. Becton Dickinson and Company Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Microneedle Flu Vaccine Distributors List Table 112. Microneedle Flu Vaccine Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Microneedle Flu Vaccine Product Image Figure 2. Global Microneedle Flu Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microneedle Flu Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Microneedle Flu Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Microneedle Flu Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Microneedle Flu Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hollow Microneedle Image Figure 9. Coated Microneedle Image Figure 10. Solid Microneedle Image Figure 11. Dissolving Microneedle Image Figure 12. Global Microneedle Flu Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Microneedle Flu Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Microneedle Flu Vaccine Sales Market Share by Type (2021-2032) Figure 15. Global Microneedle Flu Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Microneedle Flu Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Microneedle Flu Vaccine Revenue Market Share by Type (2021-2032) Figure 18. Influenza A Image Figure 19. Influenza B Image Figure 20. Global Microneedle Flu Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Microneedle Flu Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Microneedle Flu Vaccine Sales Market Share by Application (2021-2032) Figure 23. Global Microneedle Flu Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Microneedle Flu Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Microneedle Flu Vaccine Revenue Market Share by Application (2021-2032) Figure 26. North America Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Microneedle Flu Vaccine Sales Market Share by Country (2021-2032) Figure 28. U.S. Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Microneedle Flu Vaccine Sales Market Share by Country (2021-2032) Figure 33. Germany Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Microneedle Flu Vaccine Sales Market Share by Country (2021-2032) Figure 40. China Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Microneedle Flu Vaccine Sales Market Share by Country (2021-2032) Figure 48. Brazil Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Microneedle Flu Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Microneedle Flu Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Microneedle Flu Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. North America Microneedle Flu Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Microneedle Flu Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Microneedle Flu Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Microneedle Flu Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Microneedle Flu Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Microneedle Flu Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hollow Microneedle
  • Coated Microneedle
  • Solid Microneedle
  • Dissolving Microneedle
Applications
  • Influenza A
  • Influenza B
Companies covered
  • Sanofi
  • NanoPass Technologies
  • Microdermics and OraSure Technologies
  • GC Pharma
  • FluGen
  • Debiotech
  • CosMED Pharmaceuticals
  • Corium International
  • Becton Dickinson and Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microneedle Flu Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microneedle Flu Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Microneedle Flu Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Microneedle Flu Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Microneedle Flu Vaccine Market Dynamics
  1. 2.1 Microneedle Flu Vaccine Industry Trends
  2. 2.2 Microneedle Flu Vaccine Industry Drivers
  3. 2.3 Microneedle Flu Vaccine Industry Opportunities and Challenges
  4. 2.4 Microneedle Flu Vaccine Industry Restraints
3 Microneedle Flu Vaccine Market by Manufacturers
  1. 3.1 Global Microneedle Flu Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Microneedle Flu Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Microneedle Flu Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Microneedle Flu Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Microneedle Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Microneedle Flu Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Microneedle Flu Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Microneedle Flu Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Microneedle Flu Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Microneedle Flu Vaccine Tier 1, Tier 2, and Tier 3
4 Microneedle Flu Vaccine Market by Type
  1. 4.1 Microneedle Flu Vaccine Type Introduction
  2. 4.1.1 Hollow Microneedle
  3. 4.1.2 Coated Microneedle
  4. 4.1.3 Solid Microneedle
  5. 4.1.4 Dissolving Microneedle
  6. 4.2 Global Microneedle Flu Vaccine Sales by Type
  7. 4.2.1 Global Microneedle Flu Vaccine Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Microneedle Flu Vaccine Sales by Type (2021-2032)
  9. 4.2.3 Global Microneedle Flu Vaccine Sales Market Share by Type (2021-2032)
  10. 4.3 Global Microneedle Flu Vaccine Revenue by Type
  11. 4.3.1 Global Microneedle Flu Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Microneedle Flu Vaccine Revenue by Type (2021-2032)
  13. 4.3.3 Global Microneedle Flu Vaccine Revenue Market Share by Type (2021-2032)
5 Microneedle Flu Vaccine Market by Application
  1. 5.1 Microneedle Flu Vaccine Application Introduction
  2. 5.1.1 Influenza A
  3. 5.1.2 Influenza B
  4. 5.2 Global Microneedle Flu Vaccine Sales by Application
  5. 5.2.1 Global Microneedle Flu Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Microneedle Flu Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Microneedle Flu Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Microneedle Flu Vaccine Revenue by Application
  9. 5.3.1 Global Microneedle Flu Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Microneedle Flu Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Microneedle Flu Vaccine Revenue Market Share by Application (2021-2032)
6 Global Microneedle Flu Vaccine Sales by Region
  1. 6.1 Global Microneedle Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microneedle Flu Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Microneedle Flu Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Microneedle Flu Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microneedle Flu Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Microneedle Flu Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Microneedle Flu Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Microneedle Flu Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Microneedle Flu Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Microneedle Flu Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Microneedle Flu Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Microneedle Flu Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Microneedle Flu Vaccine Revenue by Region
  1. 7.1 Global Microneedle Flu Vaccine Revenue by Region
  2. 7.1.1 Global Microneedle Flu Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Microneedle Flu Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Microneedle Flu Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Microneedle Flu Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Microneedle Flu Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Microneedle Flu Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Microneedle Flu Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Microneedle Flu Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Microneedle Flu Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Microneedle Flu Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Microneedle Flu Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Microneedle Flu Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 NanoPass Technologies
  8. 8.2.1 NanoPass Technologies Company Information
  9. 8.2.2 NanoPass Technologies Business Overview
  10. 8.2.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
  12. 8.2.5 NanoPass Technologies Recent Developments
  13. 8.3 Microdermics and OraSure Technologies
  14. 8.3.1 Microdermics and OraSure Technologies Company Information
  15. 8.3.2 Microdermics and OraSure Technologies Business Overview
  16. 8.3.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
  18. 8.3.5 Microdermics and OraSure Technologies Recent Developments
  19. 8.4 GC Pharma
  20. 8.4.1 GC Pharma Company Information
  21. 8.4.2 GC Pharma Business Overview
  22. 8.4.3 GC Pharma Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
  24. 8.4.5 GC Pharma Recent Developments
  25. 8.5 FluGen
  26. 8.5.1 FluGen Company Information
  27. 8.5.2 FluGen Business Overview
  28. 8.5.3 FluGen Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 FluGen Microneedle Flu Vaccine Product Portfolio
  30. 8.5.5 FluGen Recent Developments
  31. 8.6 Debiotech
  32. 8.6.1 Debiotech Company Information
  33. 8.6.2 Debiotech Business Overview
  34. 8.6.3 Debiotech Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Debiotech Microneedle Flu Vaccine Product Portfolio
  36. 8.6.5 Debiotech Recent Developments
  37. 8.7 CosMED Pharmaceuticals
  38. 8.7.1 CosMED Pharmaceuticals Company Information
  39. 8.7.2 CosMED Pharmaceuticals Business Overview
  40. 8.7.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
  42. 8.7.5 CosMED Pharmaceuticals Recent Developments
  43. 8.8 Corium International
  44. 8.8.1 Corium International Company Information
  45. 8.8.2 Corium International Business Overview
  46. 8.8.3 Corium International Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Corium International Microneedle Flu Vaccine Product Portfolio
  48. 8.8.5 Corium International Recent Developments
  49. 8.9 Becton Dickinson and Company
  50. 8.9.1 Becton Dickinson and Company Company Information
  51. 8.9.2 Becton Dickinson and Company Business Overview
  52. 8.9.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
  54. 8.9.5 Becton Dickinson and Company Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Microneedle Flu Vaccine Value Chain Analysis
  2. 9.1.1 Microneedle Flu Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Microneedle Flu Vaccine Production Mode & Process
  6. 9.2 Microneedle Flu Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Microneedle Flu Vaccine Distributors
  9. 9.2.3 Microneedle Flu Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst